Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Ypsomed Holding AG
  6. Summary
    YPSN   CH0019396990

YPSOMED HOLDING AG

(YPSN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
09/20/2021 09/21/2021 09/22/2021 09/23/2021 09/24/2021 Date
146.8(c) 148.4(c) 154.4(c) 152.2(c) 150.4(c) Last
5 839 5 971 7 482 2 338 6 020 Volume
+0.55% +1.09% +4.04% -1.42% -1.18% Change
More quotes
Estimated financial data (e)
Sales 2022 476 M 513 M 513 M
Net income 2022 33,1 M 35,7 M 35,7 M
Net Debt 2022 229 M 247 M 247 M
P/E ratio 2022 57,2x
Yield 2022 0,46%
Sales 2023 543 M 586 M 586 M
Net income 2023 56,5 M 61,0 M 61,0 M
Net Debt 2023 204 M 220 M 220 M
P/E ratio 2023 33,7x
Yield 2023 0,82%
Capitalization 1 902 M 2 055 M 2 052 M
EV / Sales 2022 4,48x
EV / Sales 2023 3,88x
Nbr of Employees 1 737
Free-Float 25,0%
More Financials
Company
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems... 
More about the company
Ratings of Ypsomed Holding AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about YPSOMED HOLDING AG
09/07YPSOMED : Continuous therapy management via smartphone
PU
08/16YPSOMED : Credit Suisse Lifts Price Target on Ypsomed, Upgrades Recommendation to Neutral ..
MT
08/02YPSOMED : new software development site in Barcelona
PU
07/01YPSOMED : expands its options
PU
06/02YPSOMED : Alliance to Zero founded to achieve net zero emissions across the pharmaceutical..
PU
05/26Ypsomed Holding Ag Reports Earnings Results for the Full Year Ended March 31, 2021
CI
05/26GLOBAL MARKETS LIVE : Amazon, Volkswagen, AstraZeneca, Aston Martin, Sony...
05/26YPSOMED : Presentation of annual results 2020/21
PU
05/26YPSOMED : Annual Report 2020/21 (5.0 MiB)
PU
05/26YPSOMED : Investor Fact Sheet
PU
05/26YPSOMED : FY21 Profit Halves, Board Boosts Dividend
MT
05/26YPSOMED : continues to invest in growth
PU
05/21ADVAL TECH : Names Honorary Chairman
MT
04/13CEQUR : Raises $115 Million Series C5 Financing to Support Commercialization and Scale-Up ..
BU
01/04YPSOMED : Settles Dispute With Insulet Over OmniPod Distribution Deal
MT
More news
News in other languages on YPSOMED HOLDING AG
09/21AVIS D'ANALYSTES DU JOUR : Airbus, EssilorLuxottica, Porsche, Swatch, Sixt, Just Eat Takea..
09/21Bourse Zurich: le SMI repasse le cap des 11'800 points, malgré Evergrande
09/21OPINIÓN DE LOS ANALISTAS DEL DÍA : Dätwyler, HSBC, Porsche, Swatch, Sixt, Just Eat Takeawa..
09/21MADRID STOCK EXCHANGE : íCuidado, frágil!
09/21STOCK MARKET PARIS : Attention, fragile !
More news
Analyst Recommendations on YPSOMED HOLDING AG
More recommendations
Chart YPSOMED HOLDING AG
Duration : Period :
Ypsomed Holding AG Technical Analysis Chart | YPSN | CH0019396990 | MarketScreener
Technical analysis trends YPSOMED HOLDING AG
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 150,40 CHF
Average target price 161,50 CHF
Spread / Average Target 7,38%
EPS Revisions
Managers and Directors
Simon Michel Chief Executive Officer
Niklaus Ramseier CFO & Senior Vice President-Information Technology
Wilhelm Michel Non-Executive Chairman
Hans Ulrich Lehmann Senior Vice President-Technology
Frank Mengis Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
YPSOMED HOLDING AG1.48%2 055
ABBOTT LABORATORIES13.59%220 485
MEDTRONIC PLC11.00%174 982
BECTON, DICKINSON AND COMPANY1.18%72 711
HOYA CORPORATION30.69%62 143
ALIGN TECHNOLOGY, INC.35.72%57 302